PANACEA LIFE SCIENCES HOLDINGS, INC. Quarterly Operating Income (Loss) in USD from Q2 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2014 to Q1 2024.
  • Panacea Life Sciences Holdings, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$1.06M, a 18% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$5.31M, a 0.37% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2023 was -$5.55M, a 1.88% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2022 was -$5.65M, a 4.8% increase from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2021 was -$5.94M, a 12.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$5.31M -$1.06M +$233K +18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$5.55M -$1.77M -$392K -28.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$5.15M -$1.41M -$25.4K -1.83% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$5.13M -$1.07M +$166K +13.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 -$5.29M -$1.29M +$358K +21.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$5.65M -$1.38M +$772K +36% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$6.42M -$1.39M -$131K -10.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$6.29M -$1.24M +$199K +13.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$6.49M -$1.65M -$556K -51% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$5.94M -$2.15M -$2.07M -2634% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$3.87M -$1.26M +$2.09M +62.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$5.96M -$1.44M -$2.24M -279% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$3.72M -$1.09M +$1.54M +58.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$5.26M -$78.6K +$3.96M +98.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$9.21M -$3.35M -$1.33M -65.7% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-20
Q2 2020 -$7.89M $803K +$2.82M Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-20
Q1 2020 -$10.7M -$2.63M -$37.8K -1.45% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-27
Q4 2019 -$10.7M -$4.04M -$3.7M -1118% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
Q3 2019 -$6.97M -$2.02M -$1.59M -374% Jul 1, 2019 Sep 30, 2019 10-K/A 2021-04-23
Q2 2019 -$5.37M -$2.02M -$1.72M -582% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 -$3.65M -$2.6M -$1.21M -87.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 -$2.44M -$331K +$1.2M +78.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-22
Q3 2018 -$3.63M -$426K +$64.3K +13.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$3.7M -$296K +$210K +41.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$3.91M -$1.38M -$782K -130% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$3.12M -$1.53M -$780K -104% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$2.34M -$490K -$130K -36.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2.21M -$506K -$245K -94.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 -$1.97M -$601K -$368K -158% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$1.6M -$747K -$627K -521% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$974K -$360K -$257K -251% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$717K -$261K -$158K -155% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$559K -$233K -$169K -265% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$389K -$120K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$102K -$27.5K -36.8% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$102K -$85.3K -499% Apr 1, 2015 Jun 30, 2015 10-Q 2016-11-14
Q1 2015 -$64K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 -$74.9K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$17.1K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.